STAAR Surgical Company has been given the green light from China’s State Food and Drug Administration (SFDA) to market its minimally invasive ICL (Implantable Collamer Lens) products. The Visian Toric ICL has been approved for treating nearsightedness and astigmatism, while the Visian Hyperopic ICL, or Visian ICH, has been approved for correcting hyperopia or farsightedness. Both these products offer a more aesthetically pleasing outcome than competing technology due to their unique foldable design, which allows the placement of the lens behind the iris.